Spectral Diagnostics to Present at BioFinance 2012
News May 21, 2012
Spectral Diagnostics Inc., has announced that Dr. Paul Walker, the Company's President and Chief Executive Officer, will present at BioFinance 2012 on Wednesday, May 30, at 9:20 a.m. Eastern Time.
The conference will be held at the St. Andrew's Club & Conference Centre in Toronto, Ontario.
Dr. Walker will provide a corporate update, including information about the Company's pivotal sepsis program.
BioFinance is a prominent Canadian investor conference for the life sciences industry.
The two-day event brings together key industry players interested in investment opportunities and issues affecting companies in the life sciences sector.
Presenting companies span a range of industries including biologics, medical devices, drug delivery, vaccines, and diagnostics.
Penn Medicine Biochemist Receives Major Award for Research on Epigenetic Protein Modifications via Mass SpecNews
Benjamin A.Garcia, PhD, an expert in quantitative proteomics and Presidential Professor of Biochemistry and Biophysics in the Perelman School of Medicine at the University of Pennsylvania, has been awarded the Biemann Medal by the American Society for Mass Spectrometry (ASMS). The early-career award recognizes significant achievement in basic or applied mass spectrometry.
Combining Different Malaria Vaccines Could Reduce Cases by 91%News
Using two experimental anti-malarial vaccines, which work in different ways, can greatly reduce the number of malaria infections in animal studies. Experimental vaccines, which independently achieve 48% and 68% reductions in malaria cases, can achieve 91% reduction when combined.